Scrutiny plans for high-risk devices in EU face dilution
This article was originally published in SRA
Executive Summary
The Council of the EU is recommending that the scope of high-risk medical devices, which would be subject to the European Commission’s proposed “scrutiny procedure” under the new Medical Device Regulation, be substantially whittled down to include Class III implantables only, and not all Class III devices1.